PMC:7105881 / 1239-1536 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"57","span":{"begin":47,"end":53},"obj":"Species"},{"id":"58","span":{"begin":144,"end":149},"obj":"Species"},{"id":"59","span":{"begin":150,"end":154},"obj":"Species"},{"id":"60","span":{"begin":217,"end":225},"obj":"Species"},{"id":"61","span":{"begin":230,"end":238},"obj":"Species"}],"attributes":[{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"Tax:9606"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:11118"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"Tax:694009"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"Tax:1335626"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines agains"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":123,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines agains"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":217,"end":225},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines agains"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":18,"end":21},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T12","span":{"begin":47,"end":53},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T13","span":{"begin":144,"end":149},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines agains"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":123,"end":131},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines agains"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T29","span":{"begin":47,"end":53},"obj":"NCBITaxon:9606"},{"id":"T30","span":{"begin":144,"end":149},"obj":"SP_6;NCBITaxon:9606"},{"id":"T31","span":{"begin":217,"end":225},"obj":"SP_10"},{"id":"T32","span":{"begin":230,"end":238},"obj":"SP_9"},{"id":"T11552","span":{"begin":47,"end":53},"obj":"NCBITaxon:9606"},{"id":"T28582","span":{"begin":144,"end":149},"obj":"SP_6;NCBITaxon:9606"},{"id":"T48545","span":{"begin":217,"end":225},"obj":"SP_10"},{"id":"T62193","span":{"begin":230,"end":238},"obj":"SP_9"}],"text":"CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines agains"}